Diabetes News

Endocrinology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Yii MF et al. – Certain risk factors are available to assist the clinicians to identify adolescents at risk of PCOS as the signs can be masked by the normal physiological changes during puberty. It is important to screen and diagnose adolescent PCOS in order to prevent the development of future infertility, type II diabetes mellitus, cardiovascular disease, and even endometrial cancer. Lifestyle modification is of the greatest benefit for adolescents in terms of management, with the condition that full support is available from both the clinicians and their families.

Related Articles

Genotype and haplotype determination of interleukin (IL) 1beta and IL-1RN in polycystic ovary syndrome
Fertility and Sterility, 11/12/09    Relevance Score: 82%

Different phenotypes of polycystic ovary syndrome by Rotterdam criteria are differently steroidogenic but similarly insulin resistant
Fertility and Sterility, 10/06/09    Relevance Score: 82%

Dissociation of endothelial function and arterial stiffness in nonobese women with polycystic ovary syndrome (PCOS)
Clinical Endocrinology, 11/17/09    Relevance Score: 81%

Prevalence and risk of depressive disorders in women with polycystic ovary syndrome (PCOS)
Fertility and Sterility, 11/10/09    Relevance Score: 81%

Criteria for Polycystic Ovarian Morphology in Polycystic Ovary Syndrome as a Function of Age
Journal of Clinical Endocrinology and Metabolism, 11/06/09    Relevance Score: 80%

Today in Diabetes...keeping you current

Treatment with alpha-lipoic acid reduces asymmetric dimethylarginine in patients with type 2 diabetes mellitus
Translational Research, The Journal of Laboratory and Clinical Medicine, 12/11/09

Are short women at risk for gestational diabetes mellitus
European Journal of Endocrinology, 12/11/09

Insulin therapy in type 2 diabetes: insulin analogue mix 50, a potential role in reducing postprandial hyperglycaemia and cardiovascular disease
Expert Opinion in Pharmacotherapy, 12/11/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address